General Biotechnology

The Food and Drug Administration will create an independent board to more aggressively monitor the safety of drugs on the […]

The pharmaceutical industry was traumatized in 2004 when Merck had to withdraw its $2.5 billion COX-2 inhibitor Vioxx from the

Genetically Modified IP Launched A paper appearing in this week’s edition of Nature is antiseptically entitled: ‘Gene transfer to plants

From the laboratory to the investment fund How two Chilean scientists turned a graduate thesis into a business that is

Biotech: A Big Future Behind It? Despite a bumpy 2004, the rush to market hasn’t abated. The key for this

The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention

The Human Genome, Take Two When a sequenced human genome was announced in 2001, most people missed a crucial part

Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their

Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their

Financial Snapshot For December Financial Snapshot For December 2004: Sideways